Results 281 to 290 of about 391,673 (354)

Correction: Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms. [PDF]

Front Oncol
Zhao JW, Zhao WY, Yu Z.
europepmc   +1 more source

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloon (DCB) treatment has shown outcomes comparable to drug‐eluting stent (DES) in small vessel coronary disease. However, evidence for its application in large vessel coronary artery disease (CAD) remains limited. Aims This study evaluated the clinical impact of DCB‐based percutaneous coronary intervention (PCI) in ...
Eun‐Seok Shin, Mi Hee Jang, Sunwon Kim, Dong Oh Kang, Ae‐Young Her, Chang‐Bae Sohn   +5 more
wiley   +1 more source

Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey. [PDF]

Atheroscler Plus
Lyons ARM, Raal FJ, Mansfield BS, Marais D, Jessen NPJ, Appiah LT, Mbau L, Samia B, Reda A, Mekonnen TS, Damasceno A, Oljira CF, Kayikcioglu M, Zambon A.   +13 more
europepmc   +1 more source

Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The recent voluntary withdrawal of the ACURATE neo2 transcatheter aortic valve replacement device by Boston Scientific offers a compelling case study in the complex interplay of device design, clinical evidence, regulatory requirements, and market dynamics in modern structural heart interventions.
Arturo Giordano, Giuseppe Biondi‐Zoccai, David J. Cohen, Rodrigo Bagur, Nicola Corcione   +4 more
wiley   +1 more source

Cardiologists' Perceptions of Cardiogenetic Testing and Management. [PDF]

JACC Adv
Tang WHW, Bui QM, Cirino AL, Dellefave-Castillo L, Floyd BJ, Guerchicoff A, Guerchicoff M, V Khera A, Knowles JW, Lafayette K, P Landstrom A, Ma DW, Morales A, Orland KM, Pineda-Alvarez DE, Prakash SK, Theriot P, Dempsey M.   +17 more
europepmc   +1 more source

Site‐Specific Antithrombotic Therapy: 24‐Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple‐Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye, Bert Ferdinande, Johan Bennett, Rodolfo Staico, Seif El‐Jack, Pim A. L. Tonino, Alexandre Abizaid, Ian Buysschaert, Douglas Scott, Madhav Menon, Gerard Wilkins, Dougal McClean, Tomas Kovarnik, Uwe Christians, Antoinette Neylon, Zlatko Mehmedbegovic, Pieter C. Smits, Marie‐Claude Morice, Mark Webster, the DESyne BDS Plus RCT Investigators   +19 more
wiley   +1 more source

Combined atherectomy and intravascular lithotripsy in calcified coronary lesions: a meta-analysis. [PDF]

J Invasive Cardiol
Singh S, Garg A, Tantry US, Bliden K, Gurbel PA, Kochar A, Nanna MG, Damluji AA.   +7 more
europepmc   +1 more source

Coronary Flow Reserve Measured by Myocardial Perfusion Imaging in Patients Following Percutaneous Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Despite achieving complete revascularization, patients with coronary artery disease (CAD) may experience adverse outcomes, potentially attributable to coronary microvascular dysfunction (CMD). Coronary flow reserve (CFR), which integrates both epicardial and microvascular coronary function, and a reduced CFR following complete ...
Jingjing Liu, Jian Zhang, Wenhua Lin, Yuming Li   +3 more
wiley   +1 more source

American Heart Association National Integrated ASCVD Initiative: An Implementation Initiative to Improve Lipid Management Among Patients With ASCVD. [PDF]

Circ Cardiovasc Qual Outcomes
Ndumele CE, Bhatt AS, Braun LT, Chen S, Martin SS, Mullen MT, Shah NP, Sigal SL, Wang TY, Alicki R, Beon C, Hong H, O'Kane S, Overton KJ, Thomas K, Haft H.   +15 more
europepmc   +1 more source